Chadi Nabhan, MD, MBA, FACP, Chairman of the Precision Oncology Alliance, Caris Life Sciences, shares how precision medicine and personalized care have emerged as themes at this year’s Symposium, as well as some of the specific research Caris is showcasing.
Application of Genomics and Molecular Profiling for GU Malignancies
By Chadi Nabhan, MD, MBA, FACP - Last Updated: February 24, 2023Related Posts
Phouc Tran, MD, PhD, highlights the challenges of accurate risk stratification for newly diagnosed localized prostate cancer.
Daniel M. Geynisman, MD, explains the results and utility of the RETAIN trial for bladder sparing in patients with MIBC.
Petros Grivas, MD, PhD, highlights the practice-changing studies that have come out of the ASCO GU 2023 Symposium.
Michael Atkins, MD, discusses TFS outcomes from the phase II study and argues for immunotherapy in favorable-risk patients.
Steven Campbell, MD, PhD, overviews the surgical options available for patients with localized renal cell carcinoma.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.